Falcon R&D Program for Cutaneous Melanoma
Melanoma is an aggressive type of skin cancer. In melanoma we have an extensive collaboration named the Falcon R&D Program. As the falcon bird is known as an intelligent creature with unprecedented senses and skills, our R&D program is uniquely equipped to unveil new, detailed insights in the genomic, biologic and clinical nature of melanoma. Under the wings of the Falcon R&D Program, a series of specific studies and projects is initiated, aimed at developing and introducing an array of diagnostic utilities, to provide physicians with the tools to optimize the clinical pathway of their patients. Not by coincidence, related series of studies are named after birds of prey in the Falcon family.
Merlin Study Initiative
Extensive validation studies ongoing for the Merlin assay that predicts a patient’s risk for nodal metastasis. It provides a tool for physicians to identify patients that can safely forgo sentinel lymph node surgery. The Merlin assay is available as Laboratory Developed Test in our CAP/CLIA lab in San Diego.
Discover the Falcon R&D Program here!
Hematology Program for Multiple Myeloma
Our lead product MMprofilerTM with SKY92 is a clinical test used to aid physicians in the prognosis of multiple myeloma (blood cancer). It measures the activity of 92 cancer genes (SKY92), and is the most reliable test on the market to determine a patient’s prognosis. The MMprofilerTM with SKY92 is available as CE-IVD kit in Europe and as a CLIA validated Laboratory Developed Test (LDT) in the United States.
Strix Biomarker Discovery Service
Strix is the best-known genus of the Owl-family and stands for proverbial wisdom and perception. While leading a somewhat hidden nocturnal existence, this bird keeps the ecosystem well-balanced. With his sharp attention to details and incredible line of sight, Strix Serives is uniquely equipped to make visible what otherwise remains hidden. Under the wings of Strix Services, a series of specific projects have been initiated aimed at biomarker discovery, with novel peer-reviewed and in-house developed biomarker toosls. This service is now open for additional projects. Independent from the type of data, if you want to identify a sub-population through biomarkers, we will find it.
Discover the Strix Service here!